Quotient Therapeutics
Latest round
- Series A
Last raised
- Nov 2023
Total raised
- $50M
Investors
- 1
About Quotient Therapeutics
Based in London, UK, and founded in 2021, Quotient Therapeutics Limited is a biotechnology research company that focuses on the study of genetic variation at the cellular level to discover therapeutics informed by new links between genes and diseases. The company was co-founded by Jake Rubens (President). Quotient Therapeutics is developing a somatic genome platform to detect genetic variations that may contribute to diseases occurring within an individual. This initiative aims to create groundbreaking therapies for a range of conditions, including immune disease, cardiometabolic disease, infectious disease, oncology, neurodegenerative disease, rare disease, and ageing.
Who invested in Quotient Therapeutics
1 investor across 1 round
See all investors in Quotient Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 20, 2023
Amount
$50M
Investors
Questions about Quotient Therapeutics
Who invested in Quotient Therapeutics?
Quotient Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Quotient Therapeutics raised?
Quotient Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Quotient Therapeutics last raise money?
Quotient Therapeutics's most recent round on record is a Series A, in Nov 2023.
What does Quotient Therapeutics do?
Based in London, UK, and founded in 2021, Quotient Therapeutics Limited is a biotechnology research company that focuses on the study of genetic variation at the cellular level to discover therapeutics informed by new links between genes and diseases.
Where is Quotient Therapeutics headquartered?
Quotient Therapeutics is headquartered in London, UK.
Which VCs invest in companies like Quotient Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Quotient Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Quotient Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.